Safety, pharmacokinetics, and antiviral activity of RO7049389, a core protein allosteric modulator, in patients with chronic hepatitis B virus infection: a multicentre, randomised, placebo-controlled, phase 1 trial-Reference-Cited by-同舟云学术

Safety, pharmacokinetics, and antiviral activity of RO7049389, a core protein allosteric modulator, in patients with chronic hepatitis B virus infection: a multicentre, randomised, placebo-controlled, phase 1 trial

Published:2021-09 Issue:9 Volume:6 Page:723-732
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Yuen Man-Fung,Zhou Xue,Gane Edward,Schwabe Christian,Tanwandee Tawesak,Feng Sheng,Jin Yuyan,Triyatni Miriam,Lemenuel-Diot Annabelle,Cosson Valerie,Xue Zenghui,Kazma Remi,Bo Qingyan

Funder

F. Hoffmann-La Roche Ltd

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference23 articles.

1. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection;J Hepatol,2017

2. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance;Terrault;Hepatology,2018

3. Hepatitis B cure: from discovery to regulatory approval;Lok;Hepatology,2017

4. Hepatitis B virus infection;Yuen;Nat Rev Dis Primers,2018

5. Hepatitis B treatment: what we know now and what remains to be researched;Lok;Hepatol Commun,2018

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Canadian Association for the Study of the Liver Single Topic Conference on Hepatitis B Virus: ‘Progress toward hepatitis B elimination in Canada’;Canadian Liver Journal;2024-08-28

2. Phase 1 trial of the safety, pharmacokinetics, and antiviral activity of EDP-514 in untreated viremic chronic hepatitis B patients;Clinical and Molecular Hepatology;2024-07-01

3. Hepatitis B: Model Systems and Therapeutic Approaches;Journal of Immunology Research;2024-05-07

4. Efficacy, safety, and pharmacokinetics of capsid assembly modulator linvencorvir plus standard of care in chronic hepatitis B patients;Clinical and Molecular Hepatology;2024-04-01

5. Linvencovir: Paving the way for functional cure in hepatitis B;Clinical and Molecular Hepatology;2024-04-01